Key result
Inflammation, remnant cholesterol, and lipoprotein(a) contribute to residual cardiovascular risk beyond LDL cholesterol in statin-treated patients.
Design
Editorial
Answers are grounded in this paper and cite their sources.
This editorial discusses residual cardiovascular risk factors, including inflammation, remnant cholesterol, and lipoprotein(a), in statin-treated patients undergoing percutaneous coronary intervention.
This editorial refers to ‘Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention’, by B. Bay e
No takes yet. Share an insight, caveat, or question.
Wulff et al. (2025) studied this question. Inflammation, remnant cholesterol, and lipoprotein(a) contribute to residual cardiovascular risk beyond LDL cholesterol in statin-treated patients.
Synapse has enriched 10 related papers. Consider them for comparative context: